相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A White Paper-Consensus and Recommendations of a Global Harmonization Team on Assessing the Impact of Immunogenicity on Pharmacokinetic Measurements
J. M. Sailstad et al.
AAPS JOURNAL (2014)
Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics
Boris Gorovits et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
Michael S. Hershfield et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Evaluation of Pre-existing Antibody Presence as a Risk Factor for Posttreatment Anti-drug Antibody Induction: Analysis of Human Clinical Study Data for Multiple Biotherapeutics
Li Xue et al.
AAPS JOURNAL (2013)
Theoretical Considerations and Practical Approaches to Address the Effect of Anti-drug Antibody (ADA) on Quantification of Biotherapeutics in Circulation
Marian Kelley et al.
AAPS JOURNAL (2013)
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Huub Schellekens et al.
PHARMACEUTICAL RESEARCH (2013)
Immunogenicity assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine
Montserrat Carrasco-Triguero et al.
BIOANALYSIS (2013)
2013 White Paper on recent issues in bioanalysis: 'hybrid' - the best of LBA and LCMS
Lauren Stevenson et al.
BIOANALYSIS (2013)
Immunogenicity testing strategy and bioanalytical assays for antibody-drug conjugates
Sarah A. Hoofring et al.
BIOANALYSIS (2013)
Universal Immunoassay Applied During Early Development of Large Molecules to Understand Impact of Immunogenicity on Biotherapeutic Exposure
Ami C. Bautista et al.
AAPS JOURNAL (2012)
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer
Sandhya Girish et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
Ricardo P. Garay et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
2012 White Paper on Recent Issues in Bioanalysis and Alignment of Multiple Guidelines
Binodh DeSilva et al.
BIOANALYSIS (2012)
Bioanalytical Approaches to Quantify Total and Free Therapeutic Antibodies and Their Targets: Technical Challenges and PK/PD Applications Over the Course of Drug Development
Jean W. Lee et al.
AAPS JOURNAL (2011)
Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development
Alvydas Mikulskis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
2011 White Paper on Recent Issues in Bioanalysis and Regulatory Findings from Audits and Inspections
Fabio Garofolo et al.
BIOANALYSIS (2011)
A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers
Yijuan Liu et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2011)
High avidity cytokine autoantibodies in health and disease: Pathogenesis and mechanisms
Masato Watanabe et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies
Kay Stubenrauch et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
Chris H. Polman et al.
LANCET NEUROLOGY (2010)
Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment
Ami C. Bautista et al.
BIOANALYSIS (2010)
2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance
Natasha Savoie et al.
BIOANALYSIS (2010)
2009 White Paper on Recent Issues in Regulated Bioanalysis from The 3rd Calibration and Validation Group Workshop
Natasha Savoie et al.
BIOANALYSIS (2010)
The 2nd Calibration and Validation Group Workshop on recent issues in Good Laboratory Practice bioanalysis
Natasha Savoie et al.
BIOANALYSIS (2009)
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
Gopi Shankar et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
NJ Ganson et al.
ARTHRITIS RESEARCH & THERAPY (2006)